ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer's Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer's Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002 NEW YORK, Friday August 27, 2021 - ImmunoBrain Checkpoint
United Kingdom Noord Holland Carol David Kostenloser Wertpapierhandel Jesse Cedarbaum Michal Schwartz
Source: finanznachrichten.de